Changes to the website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: , which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4866

Next 25



	Website Changes

	09/14/2019		DeAngelis named MSK physician-in-chief, chief medical officer

	09/13/2019		Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer


	09/11/2019		Frankly Speaking About Brain Tumors

	09/11/2019		Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients


	09/09/2019		Bristol-Myers Squibb`s Opdivo fails 3rd straight test in tough-to-treat brain cancer

	09/09/2019		Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting


	08/30/2019		Musella Foundation awards a pediatric brain tumor research grant!

	08/15/2019		DelMar Pharmaceuticals Reports Updated Results on Twenty Patients from the Phase 2 Clinical Trial of VAL-083 as First-Line Treatment in Newly-Diagnosed MGMT-Unmethylated Glioblastoma MultiForme (GBM)


	08/15/2019		Attend an Optune Open House

	08/03/2019		Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment.


	08/03/2019		Validation of an effective implantable pump-infusion system for chronic convection-enhanced delivery of intracerebral topotecan in a large animal model.

	07/29/2019		Valerie Harper to stay out of hospice care, husband says


	07/29/2019		Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study.

	07/29/2019		Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.


	07/26/2019		Musella Foundation Brain Tumor Copay Program has reopened!

	07/20/2019		A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma


	07/19/2019		Study hints at why an aggressive form of brain cancer is hard to treat

	07/19/2019		A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)


	07/18/2019		Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma

	07/17/2019		Electricity helps control man’s brain tumor


	07/17/2019		ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company

	07/16/2019		GBM Awareness Day This Wednesday July 17th!


	07/16/2019		Neoadjuvant Anti-PD-1 Immunotherapy Leads to Survival Benefit in Recurrent Glioblastoma

	07/16/2019		Attend an Optune Open House.


	07/15/2019		Phase II study of Dovitinib in recurrent glioblastoma.